Mark Massaro
Stock Analyst at BTIG
(4.53)
# 272
Out of 5,139 analysts
177
Total ratings
55.06%
Success rate
21%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PSNL Personalis | Reiterates: Buy | $12 | $9.89 | +21.33% | 4 | Jan 9, 2026 | |
| MDXH MDxHealth | Reiterates: Buy | $7 | $3.84 | +82.29% | 10 | Dec 23, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $140 | $112.14 | +24.84% | 7 | Dec 12, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $165 → $200 | $108.08 | +85.05% | 7 | Dec 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $50 | $40.01 | +24.97% | 6 | Dec 12, 2025 | |
| BLLN BillionToOne | Reiterates: Buy | $160 | $88.73 | +80.32% | 2 | Dec 10, 2025 | |
| NTRA Natera | Maintains: Buy | $230 → $260 | $231.25 | +12.43% | 16 | Dec 5, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $160 | $124.65 | +28.36% | 4 | Dec 3, 2025 | |
| TEM Tempus AI | Maintains: Buy | $96 → $105 | $70.33 | +49.30% | 6 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $102.43 | - | 20 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $4.69 | +219.83% | 5 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $5.45 | +28.44% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $20.01 | +24.94% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $17.52 | +19.86% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $715.37 | +16.02% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.21 | +106.61% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $9.55 | -5.76% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.26 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $12.79 | +64.19% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.32 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.60 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $141.65 | +111.79% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.98 | -33.32% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $189.49 | -40.89% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $270.87 | -39.09% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $33.20 | +140.96% | 9 | Sep 10, 2018 |
Personalis
Jan 9, 2026
Reiterates: Buy
Price Target: $12
Current: $9.89
Upside: +21.33%
MDxHealth
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $3.84
Upside: +82.29%
Guardant Health
Dec 12, 2025
Maintains: Buy
Price Target: $100 → $140
Current: $112.14
Upside: +24.84%
GeneDx Holdings
Dec 12, 2025
Maintains: Buy
Price Target: $165 → $200
Current: $108.08
Upside: +85.05%
Castle Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $40.01
Upside: +24.97%
BillionToOne
Dec 10, 2025
Reiterates: Buy
Price Target: $160
Current: $88.73
Upside: +80.32%
Natera
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $231.25
Upside: +12.43%
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $124.65
Upside: +28.36%
Tempus AI
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $70.33
Upside: +49.30%
Exact Sciences
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $102.43
Upside: -
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $4.69
Upside: +219.83%
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $5.45
Upside: +28.44%
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $20.01
Upside: +24.94%
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $17.52
Upside: +19.86%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $715.37
Upside: +16.02%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.21
Upside: +106.61%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $9.55
Upside: -5.76%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.26
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $12.79
Upside: +64.19%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.32
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.60
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $141.65
Upside: +111.79%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.98
Upside: -33.32%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $189.49
Upside: -40.89%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $270.87
Upside: -39.09%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $33.20
Upside: +140.96%